메뉴 건너뛰기




Volumn 61, Issue 3, 2003, Pages 161-166

Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering

Author keywords

Crystalline zinc insulin; Intradermal test; Monomerization; Prednisolone; Protamine

Indexed keywords

ANTIHISTAMINIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; MELBIN; METFORMIN; PENFIL; PREDNISOLONE; REAGENT; RECOMBINANT HUMAN INSULIN; RECOMBINANT SOMATOMEDIN C; SOMAZON; STEROID; UNCLASSIFIED DRUG;

EID: 0042261890     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(03)00114-1     Document Type: Article
Times cited : (34)

References (25)
  • 1
    • 0027519426 scopus 로고
    • Immunogenicity and allergenic potential of animal and human insulins
    • Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diab. Care. 16:(Suppl. 3):1993;155-165.
    • (1993) Diab. Care , vol.16 , Issue.SUPPL. 3 , pp. 155-165
    • Schernthaner, G.1
  • 2
    • 0025321119 scopus 로고
    • Insulin allergy; Re-evaluation after two decades
    • Patterson R., Roberts M., Grammer L.C. Insulin allergy; re-evaluation after two decades. Ann. Allergy. 64:1990;459-462.
    • (1990) Ann. Allergy , vol.64 , pp. 459-462
    • Patterson, R.1    Roberts, M.2    Grammer, L.C.3
  • 3
    • 0030762838 scopus 로고    scopus 로고
    • Lispro analog for treatment of generalised allergy to human insulin
    • Kumar D. Lispro analog for treatment of generalised allergy to human insulin. Diab. Care. 20:1997;1357-1359.
    • (1997) Diab. Care , vol.20 , pp. 1357-1359
    • Kumar, D.1
  • 4
    • 18544404062 scopus 로고    scopus 로고
    • The insulin analog aspart: A safe alternative in insulin allergy
    • Airaghi L., Lorini M., Tedeschi A. The insulin analog aspart: a safe alternative in insulin allergy. Diab. Care. 24:2001;2000.
    • (2001) Diab. Care , vol.24 , pp. 2000
    • Airaghi, L.1    Lorini, M.2    Tedeschi, A.3
  • 5
    • 0026698991 scopus 로고
    • Altering the association properties of insulin by amino acid replacement
    • Brems D.N., Alter L.A., Beckage M.J., et al. Altering the association properties of insulin by amino acid replacement. Protein Eng. 5:1992;527-533.
    • (1992) Protein Eng. , vol.5 , pp. 527-533
    • Brems, D.N.1    Alter, L.A.2    Beckage, M.J.3
  • 7
    • 0025078913 scopus 로고
    • Monomeric insulins and their experimental and clinical implications
    • Brange J., Owens D.R., Kang S., Volund A. Monomeric insulins and their experimental and clinical implications. Diab. Care. 13:1990;923-954.
    • (1990) Diab. Care , vol.13 , pp. 923-954
    • Brange, J.1    Owens, D.R.2    Kang, S.3    Volund, A.4
  • 8
    • 0027999491 scopus 로고
    • The potential immunogenecity of human insulin and insulin analogues evaluated in a transgene mouse model
    • Ottesen J.L., Nilsson P., Jami J., et al. The potential immunogenecity of human insulin and insulin analogues evaluated in a transgene mouse model. Diabetologia. 37:1994;1178-1185.
    • (1994) Diabetologia , vol.37 , pp. 1178-1185
    • Ottesen, J.L.1    Nilsson, P.2    Jami, J.3
  • 9
    • 0034910474 scopus 로고    scopus 로고
    • Localized insulin allergy treated with continuous subcutaneous insulin
    • Pratt E.J., Miles P., Kerr D. Localized insulin allergy treated with continuous subcutaneous insulin. Diab. Med. 18:2001;515-516.
    • (2001) Diab. Med. , vol.18 , pp. 515-516
    • Pratt, E.J.1    Miles, P.2    Kerr, D.3
  • 10
    • 0035511670 scopus 로고    scopus 로고
    • Human insulin analog insulin aspart does not cause insulin allergy
    • Yasuda H., Nagata M., Moriyama H., et al. Human insulin analog insulin aspart does not cause insulin allergy. Diab. Care. 24:2001;2008-2009.
    • (2001) Diab. Care , vol.24 , pp. 2008-2009
    • Yasuda, H.1    Nagata, M.2    Moriyama, H.3
  • 11
    • 0036580827 scopus 로고    scopus 로고
    • Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes
    • Lindholm A., Jensen L.B., Home P.D., Raskin P., Boehm B.O., Rastam J. Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes. Diab. Care. 25:2002;876-882.
    • (2002) Diab. Care , vol.25 , pp. 876-882
    • Lindholm, A.1    Jensen, L.B.2    Home, P.D.3    Raskin, P.4    Boehm, B.O.5    Rastam, J.6
  • 12
    • 0020656125 scopus 로고
    • Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals
    • Schernthaner G., Borkenstein M., Fink M., Mayr W.R., Menzel J., Schober E. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Diab Care. 6:(Suppl. 1):1983;43-48.
    • (1983) Diab Care , vol.6 , Issue.SUPPL. 1 , pp. 43-48
    • Schernthaner, G.1    Borkenstein, M.2    Fink, M.3    Mayr, W.R.4    Menzel, J.5    Schober, E.6
  • 13
    • 0022532287 scopus 로고
    • Use of low-dose continuous corticosteroid infusion to facilitate insulin pump use in local insulin hypersensitivity
    • Grant W., deShazo R.D., Frentz J. Use of low-dose continuous corticosteroid infusion to facilitate insulin pump use in local insulin hypersensitivity. Diab. Care. 9:1986;318-319.
    • (1986) Diab. Care , vol.9 , pp. 318-319
    • Grant, W.1    DeShazo, R.D.2    Frentz, J.3
  • 14
    • 0031850906 scopus 로고    scopus 로고
    • Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone
    • Riddle M.C., Schneider J. Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Diab. Care. 21:1998;1052-1057.
    • (1998) Diab. Care , vol.21 , pp. 1052-1057
    • Riddle, M.C.1    Schneider, J.2
  • 16
    • 0031977357 scopus 로고    scopus 로고
    • Atomic force microscopy of crystalline insulins: The influence of sequence variation on crystallization and interfacial structure
    • Yip C.M., Brader M.L., DeFelippis M.R., Ward M.D. Atomic force microscopy of crystalline insulins: the influence of sequence variation on crystallization and interfacial structure. Biophys. J. 74:1998;2199-2209.
    • (1998) Biophys. J. , vol.74 , pp. 2199-2209
    • Yip, C.M.1    Brader, M.L.2    DeFelippis, M.R.3    Ward, M.D.4
  • 17
    • 0025286235 scopus 로고
    • Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates
    • Ratner R.E., Phillips T.M., Steiner M. Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes. 39:1990;728-733.
    • (1990) Diabetes , vol.39 , pp. 728-733
    • Ratner, R.E.1    Phillips, T.M.2    Steiner, M.3
  • 18
    • 0025735460 scopus 로고
    • A case of insulin allergy; The crystalline human insulin may mask its antigenicity
    • Takatsuki H., Ishii H., Yamauchi T., et al. A case of insulin allergy; the crystalline human insulin may mask its antigenicity. Diab. Res. Clin. Pract. 12:1991;137-139.
    • (1991) Diab. Res. Clin. Pract. , vol.12 , pp. 137-139
    • Takatsuki, H.1    Ishii, H.2    Yamauchi, T.3
  • 19
    • 0342657181 scopus 로고    scopus 로고
    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
    • Kurtzhals P., Schaffer L., Sorensen A., et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes. 49:2000;999-1005.
    • (2000) Diabetes , vol.49 , pp. 999-1005
    • Kurtzhals, P.1    Schaffer, L.2    Sorensen, A.3
  • 20
    • 0018600816 scopus 로고
    • Immunoreactivity of insulin antibodies in insulin-treated diabetics: Significance of the beta-chain carboxy-terminal amino acid (B-30) of insulin
    • Kumar D. Immunoreactivity of insulin antibodies in insulin-treated diabetics: significance of the beta-chain carboxy-terminal amino acid (B-30) of insulin. Diabetes. 28:1979;994-1000.
    • (1979) Diabetes , vol.28 , pp. 994-1000
    • Kumar, D.1
  • 21
    • 0029624346 scopus 로고
    • Primary systemic allergy to human insulin; Recurrence of generalized urticaria after successful desensitization
    • Chng H.H., Leong K.P., Loh K.C. Primary systemic allergy to human insulin; recurrence of generalized urticaria after successful desensitization. Allergy. 50:1995;984-987.
    • (1995) Allergy , vol.50 , pp. 984-987
    • Chng, H.H.1    Leong, K.P.2    Loh, K.C.3
  • 22
    • 0014602845 scopus 로고
    • Reaginic antibody against insulin; Demonstration of antigenic distinction between native and extracted insulin
    • Patterson R., Lucena G., Metz R., Roberts M. Reaginic antibody against insulin; demonstration of antigenic distinction between native and extracted insulin. J. Immunol. 103:1969;1061-1071.
    • (1969) J. Immunol. , vol.103 , pp. 1061-1071
    • Patterson, R.1    Lucena, G.2    Metz, R.3    Roberts, M.4
  • 23
    • 0033197966 scopus 로고    scopus 로고
    • Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation
    • van Neerven R.J., Wikborg T., Lund G., et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J. Immunol. 163:1999;2944-2952.
    • (1999) J. Immunol. , vol.163 , pp. 2944-2952
    • Van Neerven, R.J.1    Wikborg, T.2    Lund, G.3
  • 25
    • 0030866039 scopus 로고    scopus 로고
    • Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion
    • Nagai T., Nagai Y., Tomizawa T., Mori M. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion. Intern. Med. 36:1997;575-578.
    • (1997) Intern. Med. , vol.36 , pp. 575-578
    • Nagai, T.1    Nagai, Y.2    Tomizawa, T.3    Mori, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.